Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Activity-Dependent Internalization of Smoothened Mediated by ß-Arrestin 2 and GRK2
2004 StandoutScienceNobel
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
2017 Science
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
2013
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
2015 Science
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Adoptive T-Cell Therapy for Cancer
2016
Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera
2004
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
2016
Hallmarks of Cancer: The Next Generation
2011 Standout
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity
2017
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma
2017
Systemic Immunity Is Required for Effective Cancer Immunotherapy
2017
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping
2000
Biological functions of fucose in mammals
2017
IDH1andIDH2Mutations in Gliomas
2009 Standout
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
2003 StandoutNature
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
2015 Nature
Genetic Pathways to Primary and Secondary Glioblastoma
2007
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
2014
A guide to manufacturing CAR T cell therapies
2018
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
2014 Nature
Developing neoantigen-targeted T cell–based treatments for solid tumors
2019
The Hedgehog and Wnt signalling pathways in cancer
2001 StandoutNature
Computational genomics tools for dissecting tumour–immune cell interactions
2016
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
2002 StandoutScience
Rare and unusual glycosylation of peptides and proteins
2012
Evolving synergistic combinations of targeted immunotherapies to combat cancer
2015
Thrombospondins: from structure to therapeutics
2008
Engineered T cells: the promise and challenges of cancer immunotherapy
2016
Human and mouse proteases: a comparative genomic approach
2003
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
Malignant Gliomas in Adults
2008 Standout
6-Alkynyl fucose is a bioorthogonal analog for O-fucosylation of epidermal growth factor-like repeats and thrombospondin Type-1 repeats by protein O-fucosyltransferases 1 and 2
2012
T cell antigen discovery via trogocytosis
2019 Nobel
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
EMT: 2016
2016 Standout
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis
2016
Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
2018 StandoutNobel
Can mesenchymal cells undergo collective cell migration? The case of the neural crest
2011
Adoptive T Cell Immunotherapy For Cancer
2015
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
2016
Driving CAR T-cells forward
2016
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
2015
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Structural Prediction of Peptide–MHC Binding Modes
2022
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
2016
The present and the future in the diagnosis and management of celiac disease
2014
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
2016
Identification of human brain tumour initiating cells
2004 StandoutNature
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
2015 Nature
Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6Clow F4/80+ Extratumoral Macrophages
2015
Monitoring immune responses in the tumor microenvironment
2016
Improving the safety of cell therapy products by suicide gene transfer
2014
Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different
2018
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Liquid Biopsies and Cancer Immunotherapy
2018
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
2017
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Novel tools to assist neoepitope targeting in personalized cancer immunotherapy
2017
Evolutionary Pressure against MHC Class II Binding Cancer Mutations
2018
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Immunogenic peptide discovery in cancer genomes
2015
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
2014
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
2016
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Peptide-binding specificity prediction using fine-tuned protein structure prediction networks
2023 StandoutNobel
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Chimeric Antigen Receptor Therapy
2018 Standout
Toxicities of Immunotherapy for the Practitioner
2015
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Metabolic reprogramming and cancer progression
2020 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
The Developmental Biology of Brain Tumors
2001
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Neoantigen landscape dynamics during human melanoma–T cell interactions
2016 Nature
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Therapeutic cancer vaccines
2015
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
2014
Personalized vaccines for cancer immunotherapy
2018 Science
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
Engineering of Kuma030: A Gliadin Peptidase That Rapidly Degrades Immunogenic Gliadin Peptides in Gastric Conditions
2015 StandoutNobel
Works of Robert Somerville being referenced
Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans
2014
Anti-CD19 CAR T Cells Administered after Low-Dose Chemotherapy Can Induce Remissions of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma
2014
Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactor
2012
Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
2014 Science
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
2019
Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy
2017
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
2018
Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression
1998
Larazotide acetate regulates epithelial tight junctions in vitro and in vivo
2012
A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors
1998
The Secreted Metalloprotease ADAMTS20 Is Required for Melanoblast Survival
2008
O-Fucosylation of Thrombospondin Type 1 Repeats in ADAMTS-like-1/Punctin-1 Regulates Secretion
2007
Genetic and biochemical evidence that gastrulation defects in Pofut2 mutants result from defects in ADAMTS9 secretion
2016
Matrix metalloproteinases: old dogs with new tricks.
2003
Simplified Method of the Growth of Human Tumor Infiltrating Lymphocytes in Gas-permeable Flasks to Numbers Needed for Patient Treatment
2012
Characterization of ADAMTS-9 and ADAMTS-20 as a Distinct ADAMTS Subfamily Related to Caenorhabditis elegans GON-1
2003
Anti-CD19 chimeric antigen receptor T cells preceded by low-dose chemotherapy to induce remissions of advanced lymphoma.
2016
HPV-targeted tumor-infiltrating lymphocytes for cervical cancer.
2014
Immunogenicity of somatic mutations in human gastrointestinal cancers
2015 Science
Anti-CD19 chimeric antigen receptor T cells preceded by low-dose chemotherapy to induce remissions of advanced lymphoma.
2016
Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma
2013
HPV-targeted tumor-infiltrating lymphocytes for cervical cancer.
2014